Insurance data analysis uncovers real-world behaviors
Screening high-risk patients early may be the way to go
Researchers see patient subgroups with higher clot risk
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
How care is being transformed at Cleveland Clinic
Program to study DNA, RNA alterations, test targeted therapies
Results from Phase III CATCH trial add data to what was already a consensus-driven treatment option: low-molecular weight heparin.
Specialized team focuses on research, reducing costs